These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31268768)

  • 1. End TB Strategy: Time to Move on From the Skin Test to the Interferon-
    Kruse M; Cruikshank W
    Am J Public Health; 2019 Aug; 109(8):1102-1104. PubMed ID: 31268768
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing International Adoptees for Tuberculosis.
    Priya Dhar C; Elena Gonzalez B; Dragga T; Bothe D; Mandalakas AM
    Pediatr Infect Dis J; 2015 Oct; 34(10):1138-9. PubMed ID: 26367807
    [No Abstract]   [Full Text] [Related]  

  • 4. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
    Santos JA; Duarte R; Nunes C
    Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Latent Tuberculosis Infection.
    Lardizabal AA; Reichman LB
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Interferon-gamma Release Assays in the Screening of Latent Tuberculosis Infection in Immigrant and Internationally Adopted Children.
    Méndez-Echevarría A; Sainz T; García-Hortelano M; Baquero-Artigao F; Mellado MJ
    Pediatr Infect Dis J; 2015 Oct; 34(10):1141-2. PubMed ID: 26367809
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuberculin skin test and/or interferon gamma release assay: is it still time to debate?
    Sanduzzi A; Marchetiello I; Bocchino M; Boccia G; De Caro F
    Infez Med; 2017 Mar; 25(1):80-81. PubMed ID: 28353462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contact tracing in low-incidence tuberculosis settings.
    van Leth F; Borgdorff M
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1566. PubMed ID: 22118163
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality control in QuantiFERON-TB gold in-tube for screening latent tuberculosis infection in health care workers.
    Igari H; Watanabe A; Ichimura Y; Sakurai T; Taniguchi T; Ishiwada N
    J Infect Chemother; 2017 Apr; 23(4):211-213. PubMed ID: 28094124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers.
    Tanabe M; Nakamura A; Arai A; Yamasaki D; Hirano K; Kobayashi T; Taguchi O; Kaneko T; Ito M
    Intern Med; 2017; 56(7):773-779. PubMed ID: 28381742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of interferon-γ release assay on the latent tuberculosis cascade of care: a population-based study.
    Roth DZ; Ronald LA; Ling D; Chiang LY; Cook VJ; Morshed MG; Johnston JC
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331032
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of interferon-gamma release assay for latent tuberculosis infection screening in older adults exposed to tuberculosis in a nursing home.
    Katsenos S; Nikolopoulou M; Gartzonika C; Manda-Stachouli C; Gogali A; Grypaiou C; Mavridis A; Constantopoulos SH; Daskalopoulos G
    J Am Geriatr Soc; 2011 May; 59(5):858-62. PubMed ID: 21517785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test?
    Cabriada JL; Ruiz-Zorrilla R; Barrio J; Atienza R; Huerta A; Rodríguez-Lago I; Bernal A; Herrero C
    Turk J Gastroenterol; 2018 May; 29(3):292-298. PubMed ID: 29755013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TB screening in an HIV clinic: how interferon-gamma assays improve screening compliance.
    O'Neal WT; Winters MW; Augustino KL; Fang X; Cook PP
    Int J Tuberc Lung Dis; 2012 May; 16(5):707. PubMed ID: 22507941
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases.
    Papay P; Eser A; Winkler S; Frantal S; Primas C; Miehsler W; Angelberger S; Novacek G; Mikulits A; Vogelsang H; Reinisch W
    Eur J Clin Invest; 2011 Oct; 41(10):1071-6. PubMed ID: 21413978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.